Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Suneeta Sunny

Long COVID: Study Says Synbiotic Drug That Alters Gut Microbiome Relieves Multiple Symptoms

The results of the trial indicate that the drug SIM01 could help alleviate symptoms including fatigue, gastrointestinal upset, difficulty in concentration, memory loss, and general unwellness. (Credit: pixabay/ jarmoluk)

An experimental drug that alters the gut microbiome could help relieve multiple symptoms of long COVID, a randomized controlled trial has revealed.

Post-acute COVID-19 syndrome (PACS), or long COVID, is a multisystem disorder that affects over 65 million people worldwide. As of now, there is no recognized and effective treatment for the condition that impacts the quality of life of those affected.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.